Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation-Reference-Cited by-同舟云学术

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

Published:2015-05-05 Issue:4 Volume:170 Page:574-583
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

ElSawy Mahmoud¹²,Storer Barry E.³⁴,Pulsipher Michael A.⁵⁶,Maziarz Richard T.⁷⁸,Bhatia Smita⁹,Maris Michael B.¹⁰,Syrjala Karen L.¹¹¹,Martin Paul J.¹¹²,Maloney David G.¹¹²,Sandmaier Brenda M.¹¹²,Storb Rainer¹¹²,Sorror Mohamed L.¹¹²

Affiliation:

1. Clinical Research Division; Fred Hutchinson Cancer Research Center; Seattle WA USA

2. National Cancer Institute; Cairo University; Cairo Egypt

3. Clinical Statistics Program; Clinical Research Division; Fred Hutchinson Cancer Research Center; Seattle WA USA

4. Department of Biostatistics; University of Washington School of Public Health; Seattle WA USA

5. Division of Hematology/Blood and Marrow Transplantation; University of Utah School of Medicine; Logan UT USA

6. Pediatric Blood and Marrow Transplant Program; Primary Children's Medical Center; Huntsman Cancer Institute; Salt Lake City UT USA

7. Center for Hematologic Malignancies; OHSU Knight Cancer Institute; Portland OR USA

8. Division of Hematology and Medical Oncology; Oregon Health & Science University School of Medicine; Portland OR USA

9. Department of Population Sciences; Center for Cancer Survivorship; City of Hope School of Medicine; Duarte CA USA

10. Colorado Blood Cancer Institute School of Medicine; Denver CO USA

11. Department of Psychiatry and Behavioral Sciences; University of Washington School of Medicine Seattle; Seattle WA USA

12. Division of Medical Oncology; Department of Medicine; University of Washington School of Medicine; Seattle WA USA

Funder

National Institutes of Health

American Cancer Society

Patient-Centered Outcomes Research Institute

Ministry of Higher Education, Egypt

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13476/fullpdf

Reference32 articles.

1. The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation;Abou-Nassar;Biology of Blood & Marrow Transplantation,2012

2. Defining the intensity of conditioning regimens: working definitions;Bacigalupo;Biology of Blood and Marrow Transplantation,2009

3. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI is the best predictor of NRM and OS in a population of patients undergoing allo-RIC;Barba;Biology of Blood and Marrow Transplantation,2010

4. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation-investigation of potential limitations of the index;Birninger;Biology of Blood and Marrow Transplantation,2011

5. Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation;Bokhari;Bone Marrow Transplantation,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease;Bone Marrow Transplantation;2024-08-26

2. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024;Journal of the National Comprehensive Cancer Network;2024-04

3. Gastrointestinal Involvement Refines Prognosis in Minnesota Standard Risk Acute Graft-vs-Host Disease;2024-02-05

4. Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021;Hematological Oncology;2023-12-06

5. Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC;Bone Marrow Transplantation;2023-08-31